Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
OTCMKTS · Delayed Price · Currency is USD
3.300
0.00 (0.00%)
At close: Oct 7, 2025
SFOSF Market Cap
SFOSF has a market cap or net worth of $10.11 billion as of October 17, 2025. Its market cap has increased by 34.59% in one year.
Market Cap
10.11B
Enterprise Value
14.89B
Revenue
5.60B
Ranking
n/a
PE Ratio
22.31
Stock Price
$3.30
Market Cap Chart
Since August 9, 2005, SFOSF's market cap has increased from 539.79M to 10.11B, an increase of 1,773.43%. That is a compound annual growth rate of 15.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2025 | 10.27B | 25.49% |
| Dec 31, 2024 | 8.19B | -5.76% |
| Dec 29, 2023 | 8.69B | -31.08% |
| Dec 30, 2022 | 12.60B | -29.69% |
| Dec 31, 2021 | 17.92B | -6.98% |
| Dec 31, 2020 | 19.27B | 106.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 698.88M |
| Elite Pharmaceuticals | 663.06M |
| Veradigm | 514.01M |
| Nika Pharmaceuticals | 495.49M |
| Northwest Biotherapeutics | 367.43M |
| CytoDyn | 350.21M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 275.85M |